SPEC vs. TSTL, BVC, AKR, CNSL, ODX, CTEC, AMS, ANCR, CIR, and DXRX
Should you be buying INSPECS Group stock or one of its competitors? The main competitors of INSPECS Group include Tristel (TSTL), BATM Advanced Communications (BVC), Akers Biosciences (AKR), Cambridge Nutritional Sciences (CNSL), Omega Diagnostics Group (ODX), ConvaTec Group (CTEC), Advanced Medical Solutions Group (AMS), Animalcare Group (ANCR), Circassia Group (CIR), and Diaceutics (DXRX). These companies are all part of the "medical" sector.
INSPECS Group vs. Its Competitors
Tristel (LON:TSTL) and INSPECS Group (LON:SPEC) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, earnings, risk, media sentiment, institutional ownership, profitability, analyst recommendations and valuation.
Tristel presently has a consensus target price of GBX 400, indicating a potential upside of 10.19%. INSPECS Group has a consensus target price of GBX 60, indicating a potential upside of 27.39%. Given INSPECS Group's stronger consensus rating and higher probable upside, analysts plainly believe INSPECS Group is more favorable than Tristel.
Tristel has a beta of 0.23, indicating that its stock price is 77% less volatile than the S&P 500. Comparatively, INSPECS Group has a beta of 2.22, indicating that its stock price is 122% more volatile than the S&P 500.
In the previous week, Tristel had 1 more articles in the media than INSPECS Group. MarketBeat recorded 1 mentions for Tristel and 0 mentions for INSPECS Group. Tristel's average media sentiment score of 0.00 equaled INSPECS Group'saverage media sentiment score.
Tristel has a net margin of 15.47% compared to INSPECS Group's net margin of -2.10%. Tristel's return on equity of 20.43% beat INSPECS Group's return on equity.
37.8% of Tristel shares are owned by institutional investors. Comparatively, 27.1% of INSPECS Group shares are owned by institutional investors. 21.1% of Tristel shares are owned by company insiders. Comparatively, 20.6% of INSPECS Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Tristel has higher earnings, but lower revenue than INSPECS Group. INSPECS Group is trading at a lower price-to-earnings ratio than Tristel, indicating that it is currently the more affordable of the two stocks.
Summary
Tristel beats INSPECS Group on 10 of the 15 factors compared between the two stocks.
Get INSPECS Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for SPEC and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding SPEC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
INSPECS Group Competitors List
Related Companies and Tools
This page (LON:SPEC) was last updated on 10/8/2025 by MarketBeat.com Staff
